Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
559
Total Claims
$923K
Drug Cost
170
Beneficiaries
$5,432
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
-3%
Opioid rate vs peers
6.1% vs 6.3% avg
-60%
Cost per patient vs peers
$5,432 vs $14K avg
+7%
Brand preference vs peers
15.6% vs 14.6% avg
Opioid Prescribing
6.1%
Opioid Rate
34
Opioid Claims
$1,350
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 87 claims · $791K
Generic: 472 claims · $133K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Lenalidomide | 12 | $243K |
| Enzalutamide | 14 | $133K |
| Apixaban | 18 | $18K |
| Letrozole | 56 | $2,357 |
| Anastrozole | 100 | $2,215 |
| Hydroxyurea | 25 | $996 |
| Tamoxifen Citrate | 15 | $505 |
| Dexamethasone | 20 | $422 |
| Alendronate Sodium | 24 | $342 |
| Prochlorperazine Maleate | 29 | $334 |
| Lidocaine/Prilocaine | 15 | $266 |
| Acyclovir | 13 | $162 |
| Prednisone | 13 | $91 |
Prescribing Profile
Patient Profile
74
Avg Age
69%
Female
1.50
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About